Articles about seagen

Pfizer to close Seagen manufacturing plant in Seattle area following $43B acquisition

Pharma giant Pfizer, fresh off its $43 billion acquisition of Seagen, said it will shut down construction on a new… Read More

How Pfizer’s $43B acquisition of Seagen may impact Seattle and broader biotech market

Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. … Read More

Pfizer wins regulatory approval for its $43B acquisition of Seattle-area biotech giant Seagen

Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The… Read More

Startup led by former Seagen CEO Clay Siegall merges with public company in $125M deal

Morphimmune, a biotech company led by former Seagen CEO Clay Siegall, is merging with a public biotech company, Immunome, in… Read More

Seagen filing details M&A negotiations with several companies before $43B Pfizer deal

Seagen fielded multiple offers before agreeing to a whopping $43 billion acquisition by pharma giant Pfizer. The Seattle-area company revealed… Read More

Q&A with Seagen founder Clay Siegall on the Pfizer deal and his new biotech startup

Clay Siegall is proud of his legacy as co-founder and longtime CEO of Seagen, the largest biotech company in the… Read More

Seagen founder Clay Siegall is back in biotech as CEO of Purdue University spinout

Seagen founder Clay Siegall is jumping back into the biotech world as CEO and president of Morphimmune. Founded in 2020,… Read More

Biotech experts wary of Pfizer cutting Seagen workforce — but history reveals silver lining

Seattle-area biotech experts are eying the past warily in the wake of this week’s news that Pfizer plans to acquire… Read More

How Pfizer’s $43 billion acquisition of Seagen could impact the biotech industry in Seattle

Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed. Whether that happens to Seagen is… Read More

Pfizer will acquire Seattle-area biotech giant Seagen for $43 billion

Pfizer is buying Seattle-area biotech giant Seagen in a massive $43 billion deal announced Monday. The deal is the largest… Read More

Seagen stock rises as Pfizer reportedly in talks to acquire Seattle-area biotech giant

Biopharma giant Pfizer is eyeing an acquisition of Seagen, the biggest biotech company in the Seattle area, according to a report in… Read More

Seagen vets land $4.4M for Univ. of Washington spinout using fresh approach for cancer vaccines

A biotech startup spun out of the University of Washington and led by veterans of Seattle-area biotech giant Seagen has… Read More

Ex-Seagen CEO Clay Siegall won’t face charges following arrest, domestic violence allegations

Clay Siegall, the former CEO and chairman of Seattle-area biotech giant Seagen, will not face charges stemming from an arrest… Read More

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs

Sujal Patel has been here before. He weathered the 2009 recession as CEO of Isilon Systems, coming out the other… Read More

Tech Moves: Seagen names new CEO; Amazon hires director of corporate development; and more

— Seattle biotech giant Seagen has appointed a new CEO, David Epstein, a former executive at Novartis. Epstein also joined… Read More

Seagen inks deal with Dutch biotech to develop and commercialize drug candidate

Seagen has inked a deal to develop, manufacture and commercialize an experimental immuno-oncology agent from Lava Therapeutics, a biotech company… Read More

Seagen reports $498M in Q2 revenue, stays silent on reported sale to Merck

Seagen reported second quarter revenue of $498 million, up 28%, beating analyst expectations. The company also recently reported “positive” early… Read More

Report: Merck in ‘advanced talks’ to acquire Seattle-area biotech giant Seagen for around $40B

A new Wall Street Journal report revealed that Merck is in “advanced talks” to acquire Seattle-area biotech giant Seagen in… Read More

Merck reportedly eyeing acquisition of Seattle biotech giant Seagen

Biopharma giant Merck is considering an acquisition of Seagen, the Seattle area’s biggest biotech company, according to a report in… Read More

Life sciences news: New startups, fundings, mergers, clinical trials, partnerships

Here’s a rundown of life sciences and health news across the Pacific Northwest this week. Talus Bioscience raised $9.75 million.… Read More

Life sciences news: Seattle researchers make Time list; ‘blowing apart’ academic promotion; and more

It was a week of accolades, partnerships and new programs in the Pacific Northwest life sciences scene. University of Washington… Read More

Life sciences news: Seagen CEO resigns after arrest, cautious optimism for biotech, and more

Here’s a rundown of the top life sciences and health news across the Pacific Northwest this week. Seagen CEO resigns… Read More

Seagen CEO and co-founder Clay Siegall resigns following domestic violence arrest

Clay Siegall has resigned as CEO and chairman of Seagen in the midst of domestic violence allegations, more than 24… Read More

Biotech giant Seagen reveals plans for 270K square-foot manufacturing facility near Seattle

Seagen is expanding its manufacturing capacity in the Seattle area. The fast-growing global biotech company will build a 270,000 square-foot… Read More

Latest life sciences news: COVID-19 nasal spray; disease reversal; Amazon’s healthcare priorities

This week we highlighted the finalists for Health Innovation of the Year at the GeekWire Awards. The finalists showcase the… Read More

ProfoundBio, led by Seagen veterans and co-located in China and Seattle, raises $55M

ProfoundBio, based in Woodinville, Wash., and Suzhou, China, has raised $55 million in a Series A funding round to advance… Read More